Program Information
Improved Patient-Specific Optimization of the Stopping Power Calibration for Proton Therapy Planning Using a Single Proton Radiography
I Rinaldi1,2,3*, M Testa4,5, S Brons6, O Jaekel3,6,7, K Parodi2,6 , B Voss8, N Krah9 (1) Lyon 1 University and CNRS/IN2P3, UMR 5822, Villeurbanne, France (2) Ludwig Maximilian University, Garching, Germany (3) Department of Radiation Therapy and Oncology, Heidelberg University Hospital, Heidelberg, Germany (4) Department of Radiation Oncology, Massachusetts General Hospital, Boston, USA (5) Department of Radiation Convergence Engineering, Yonsei University, Wonju, South-Korea (6) Heidelberg Ion Therapy Center, Heidelberg, Germany (7) German Cancer Research Center, Heidelberg, Germany (8) GSI Helmholtz Center for Heavy Ion Research, Darmstadt, Germany (9) Heidelberg Collaboratory for Image Processing, Heidelberg, Germany
Presentations
SU-C-204-2 (Sunday, July 12, 2015) 1:00 PM - 1:55 PM Room: 204
Purpose:
We present an improved method to calculate patient-specific calibration curves to convert X-ray computed tomography (CT) Hounsfield Unit (HU) to relative stopping powers (RSP) for proton therapy treatment planning.
Methods:
By optimizing the HU-RSP calibration curve, the difference between a proton radiographic image and a digitally reconstructed X-ray radiography (DRR) is minimized. The feasibility of this approach has previously been demonstrated. This scenario assumes that all discrepancies between proton radiography and DRR originate from uncertainties in the HU-RSP curve. In reality, external factors cause imperfections in the proton radiography, such as misalignment compared to the DRR and unfaithful representation of geometric structures (“blurring”). We analyze these effects based on synthetic datasets of anthropomorphic phantoms and suggest an extended optimization scheme which explicitly accounts for these effects. Performance of the method is been tested for various simulated irradiation parameters.
The ultimate purpose of the optimization is to minimize uncertainties in the HU-RSP calibration curve. We therefore suggest and perform a thorough statistical treatment to quantify the accuracy of the optimized HU-RSP curve.
Results:
We demonstrate that without extending the optimization scheme, spatial blurring (equivalent to FWHM=3mm convolution) in the proton radiographies can cause up to 10% deviation between the optimized and the ground truth HU-RSP calibration curve. Instead, results obtained with our extended method reach 1% or better correspondence. We have further calculated gamma index maps for different acceptance levels. With DTA=0.5mm and RD=0.5%, a passing ratio of 100% is obtained with the extended method, while an optimization neglecting effects of spatial blurring only reach ~90%.
Conclusion:
Our contribution underlines the potential of a single proton radiography to generate a patient-specific calibration curve and to improve dose delivery by optimizing the HU-RSP calibration curve as long as all sources of systematic incongruence are properly modeled.
Contact Email: